Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ADUSNASDAQ:AHCONASDAQ:AMEDNYSE:CHE On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeADUSAddus HomeCare$113.79-1.2%$108.91$88.96▼$136.72$2.12B0.81170,652 shs195,824 shsAHCOAdaptHealth$8.39-1.1%$8.59$7.11▼$11.90$1.14B1.641.31 million shs4.10 million shsAMEDAmedisys$97.46-0.4%$94.66$82.15▼$98.95$3.21B0.94419,797 shs635,871 shsCHEChemed$547.06+0.2%$567.63$512.12▼$623.61$7.99B0.54105,403 shs245,728 shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceADUSAddus HomeCare-1.19%+0.88%+3.30%+26.67%-4.62%AHCOAdaptHealth-1.06%-2.44%-7.40%-16.02%-25.36%AMEDAmedisys-0.44%+0.31%+4.14%+5.50%+6.36%CHEChemed+0.19%-0.59%-4.25%-7.97%+2.75%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationADUSAddus HomeCare4.6357 of 5 stars3.62.00.05.02.62.51.9AHCOAdaptHealth3.8508 of 5 stars3.51.00.00.03.11.73.8AMEDAmedisys3.3091 of 5 stars1.13.00.05.02.91.71.3CHEChemed4.6848 of 5 stars2.53.03.34.93.52.51.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceADUSAddus HomeCare 3.25Buy$142.5725.29% UpsideAHCOAdaptHealth 3.00Buy$13.4059.71% UpsideAMEDAmedisys 2.20Hold$100.753.38% UpsideCHEChemed 3.00Buy$674.0023.20% UpsideCurrent Analyst Ratings BreakdownLatest AMED, CHE, ADUS, and AHCO Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/20/2025ADUSAddus HomeCareJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$150.006/10/2025ADUSAddus HomeCareMacquarieSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$133.005/12/2025AHCOAdaptHealthTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$14.00 ➝ $13.005/8/2025ADUSAddus HomeCareMacquarieSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$129.00 ➝ $133.005/8/2025AHCOAdaptHealthRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$14.00 ➝ $13.004/28/2025CHEChemedRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$667.00 ➝ $674.004/22/2025ADUSAddus HomeCareJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$150.00 ➝ $150.004/16/2025AMEDAmedisysRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$100.00 ➝ $100.004/10/2025ADUSAddus HomeCareJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$150.00 ➝ $150.00(Data available from 6/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookADUSAddus HomeCare$1.15B1.81$5.32 per share21.37$53.52 per share2.13AHCOAdaptHealth$3.26B0.35$3.75 per share2.24$11.72 per share0.72AMEDAmedisys$2.35B1.36$6.20 per share15.71$36.03 per share2.70CHEChemed$2.43B3.29$25.76 per share21.24$74.35 per share7.36Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateADUSAddus HomeCare$73.60M$4.4325.6921.231.636.52%9.23%6.96%8/4/2025 (Estimated)AHCOAdaptHealth$90.42M$0.5714.728.650.982.63%6.96%2.40%8/5/2025 (Estimated)AMEDAmedisys$43.23M$2.7135.9620.141.333.79%12.52%7.01%7/23/2025 (Estimated)CHEChemed$302M$20.5326.6523.482.2712.40%27.58%18.96%7/23/2025 (Estimated)Latest AMED, CHE, ADUS, and AHCO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/5/2025Q1 2025ADUSAddus HomeCare$1.33$1.42+$0.09$1.16$341.66 million$337.71 million4/23/2025Q1 2025AMEDAmedisys$1.13$1.25+$0.12$1.84$597.43 million$594.78 million4/23/2025Q1 2025CHEChemed$5.59$5.63+$0.04$4.86$641.78 million$646.94 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthADUSAddus HomeCareN/AN/AN/AN/AN/AAHCOAdaptHealthN/AN/AN/AN/AN/AAMEDAmedisysN/AN/AN/AN/AN/ACHEChemed$2.000.37%N/A9.74%16 YearsLatest AMED, CHE, ADUS, and AHCO DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/20/2025CHEChemedquarterly$0.500.3%5/29/20255/29/20256/17/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioADUSAddus HomeCare0.201.741.74AHCOAdaptHealth1.251.291.07AMEDAmedisys0.271.291.29CHEChemedN/A1.731.70Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipADUSAddus HomeCare95.35%AHCOAdaptHealth82.67%AMEDAmedisys94.36%CHEChemed95.85%Insider OwnershipCompanyInsider OwnershipADUSAddus HomeCare4.60%AHCOAdaptHealth1.55%AMEDAmedisys2.10%CHEChemed3.29%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableADUSAddus HomeCare49,70318.40 million17.55 millionOptionableAHCOAdaptHealth10,500134.95 million132.86 millionOptionableAMEDAmedisys19,00032.82 million32.13 millionOptionableCHEChemed15,69514.63 million14.15 millionOptionableAMED, CHE, ADUS, and AHCO HeadlinesRecent News About These Companies5 Must-Read Analyst Questions From Chemed’s Q1 Earnings CallJune 20 at 1:15 PM | msn.comChemed Corporation (NYSE:CHE) Stock Position Decreased by Riverbridge Partners LLCJune 20 at 6:06 AM | marketbeat.com510 Shares in Chemed Corporation (NYSE:CHE) Bought by Silver Oak Securities IncorporatedJune 20 at 5:30 AM | marketbeat.comChemed Corporation (NYSE:CHE) Short Interest Up 23.2% in MayJune 19 at 3:52 PM | marketbeat.comChemed Corporation (NYSE:CHE) Shares Purchased by Boston Trust Walden CorpJune 19 at 6:15 AM | marketbeat.comHere's How Much $1000 Invested In Chemed 10 Years Ago Would Be Worth TodayJune 17, 2025 | benzinga.comSG Americas Securities LLC Makes New Investment in Chemed Co. (NYSE:CHE)June 17, 2025 | marketbeat.comTrust Point Inc. Sells 916 Shares of Chemed Co. (NYSE:CHE)June 16, 2025 | marketbeat.comFifth Third Bancorp Has $2.55 Million Stake in Chemed Co. (NYSE:CHE)June 15, 2025 | marketbeat.comFort Washington Investment Advisors Inc. OH Sells 1,143 Shares of Chemed Co. (NYSE:CHE)June 13, 2025 | marketbeat.comSenior Health, Home Health & Hospice Stocks Q1 In Review: Chemed (NYSE:CHE) Vs PeersJune 9, 2025 | msn.comHennion & Walsh Asset Management Inc. Purchases 646 Shares of Chemed Co. (NYSE:CHE)June 8, 2025 | marketbeat.comVest Financial LLC Acquires New Position in Chemed Co. (NYSE:CHE)June 7, 2025 | marketbeat.comChemed Co. (NYSE:CHE) Shares Sold by Wellington Management Group LLPJune 7, 2025 | marketbeat.com3 Reasons CHE is Risky and 1 Stock to Buy InsteadJune 7, 2025 | msn.comChemed Co. (NYSE:CHE) Shares Purchased by Signal Advisors Wealth LLCJune 6, 2025 | marketbeat.com834 Shares in Chemed Co. (NYSE:CHE) Bought by NBC Securities Inc.June 6, 2025 | marketbeat.comRhumbline Advisers Decreases Holdings in Chemed Co. (NYSE:CHE)June 5, 2025 | marketbeat.comChemed Co. (NYSE:CHE) Short Interest UpdateJune 2, 2025 | marketbeat.comChemed Co. (NYSE:CHE) Shares Acquired by GAMMA Investing LLCJune 2, 2025 | marketbeat.comTwo Sigma Investments LP Sells 3,255 Shares of Chemed Co. (NYSE:CHE)June 1, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Penny Stocks Analysts Believe Are Headed HigherBy Chris Markoch | June 4, 2025View 3 Penny Stocks Analysts Believe Are Headed Higher3 Catalysts in 7 Days: Archer's Growth Story Just AcceleratedBy Jeffrey Neal Johnson | June 18, 2025View 3 Catalysts in 7 Days: Archer's Growth Story Just AcceleratedAST SpaceMobile’s Star Is Rising: Get in While It’s Still Cheap!By Thomas Hughes | June 16, 2025View AST SpaceMobile’s Star Is Rising: Get in While It’s Still Cheap!Government Mandate Sends eVTOL Stocks FlyingBy Jeffrey Neal Johnson | June 10, 2025View Government Mandate Sends eVTOL Stocks FlyingArcher's Midnight Air Taxi Soars, But Stock Doesn’t BudgeBy Jeffrey Neal Johnson | June 4, 2025View Archer's Midnight Air Taxi Soars, But Stock Doesn’t BudgeAMED, CHE, ADUS, and AHCO Company DescriptionsAddus HomeCare NASDAQ:ADUS$113.79 -1.37 (-1.19%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$114.60 +0.81 (+0.72%) As of 06/20/2025 05:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.AdaptHealth NASDAQ:AHCO$8.39 -0.09 (-1.06%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$8.49 +0.10 (+1.25%) As of 06/20/2025 06:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.Amedisys NASDAQ:AMED$97.46 -0.43 (-0.44%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$97.47 +0.01 (+0.01%) As of 06/20/2025 05:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.Chemed NYSE:CHE$547.06 +0.98 (+0.18%) Closing price 06/20/2025 03:59 PM EasternExtended Trading$548.06 +1.00 (+0.18%) As of 06/20/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New All-Time Highs Coming for Broadcom? Wall Street Says Yes Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer 3 Reasons AMD Could Be the Hottest Stock of the Summer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Robinhood Director Sells Millions, But HOOD Stock Eyes Gains Coinbase Stock Pops as Senate Passes GENIUS Stablecoin Bill Overheated Market? Analysts Watch These Red Flags Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
